Nuvig, Maze, and Antag close funding rounds In other financing news this week, immunomodulation therapy developer Nuvig Therapeutics ... and Nuvig's preclinical pipeline. NVG-2089 is designed ...

Discover why Altimmune (ALT) and Viking Therapeutics (VKTX) are top picks for high-risk investors. Click here to read my most ...

What potential does the company’s pipeline hold for addressing unmet medical needs? Contineum Therapeutics’ pipeline holds significant potential for addressing unmet medical needs across ...

Fate Therapeutics FATE reported a loss of 32 cents ... Its immuno-oncology pipeline includes iPSC-derived natural killer (NK) cells and T-cell product candidates. A phase I study of FT819, a ...

What potential does the company’s pipeline hold for addressing unmet medical needs? Contineum Therapeutics’ pipeline holds significant potential for addressing unmet medical needs across several ...

The company also has several candidates in its pipeline as can be seen above. United Therapeutics is trying to position Tyvaso to treat idiopathic pulmonary fibrosis, where it would have Orphan ...

It also covers the Peritoneal Cancer pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in ...

The strategic partnership is likely to diversify CRISPR Therapeutics’ pipeline by adding Sirius’s lead candidate, SRSD107, a next-generation, long-acting siRNA therapy, which is being ...

It also covers the Mucopolysaccharidosis Type I pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline ...